Responding to a popular request, we are now sharing transcripts of our investor podcast interviews in this new series. The following interview with Charlie O’Donnell, Brooklyn Bridge Ventures was recorded in November 2017. Charlie O’Donnell, Partner at Brooklyn Bridge Ventures, talks about his Seed investing activities and related industry trends. Sramana Mitra: Let’s start by getting acquainted.
This feature from The New York Times examines how the doctor-patient relationship saves lives as well as money and makes a case for reinventing the primary care delivery. For this week’s posts, click on the paragraph links.
Sramana Mitra: The issue that we are seeing is that a lot of companies are not ready for a $5 million to $10 million Series A. We need funds that can do $1 million to $3 million Series A. That’s only viable if the fund sizes are relatively small. The larger fund sizes cannot do
Sramana Mitra: I do want to finish by having you talk to us a little bit about what stage you invest in. You talked a lot about the segment and preference in B2B. Talk to us about stage as a concluding segment. David Blumberg: We believe that there are many brilliant entrepreneurs all over the
Sramana Mitra: It’s the same kind of architecture that you are doing with your product. You’re catering to the pharmaceutical industry across their use cases and drawing hua ndred sources of data. You’re suggesting a similar architecture but catering to the end user. William King: Yes. If you think about the great companies, Apple has
Sramana Mitra: It’s interesting to see that you guys are seeing AI in the midwest as well. It’s good to know that that’s a pervasive trend even in your part of the universe. From your fund’s point of view, what kind of ventures are you looking to invest in? What is your investment thesis and
Sramana Mitra: This is an area of differentiated well-merchandised consumer products in existing categories and sometimes even new categories. This is a very interesting area because Facebook has created an unbelievable platform for entrepreneurs to hyper-target. That hyper-targeting capability never existed until now. It’s amazing. For $20, the kind of hyper-targeting you can do is
Sramana Mitra: Do you have a sense of the state of the union of all that? It seems like Apple is taking a decisive position on trying to play a big role in the quantified self movement. What is your assessment? What’s happening? Who’s doing what? A small startup can’t take Apple on given where